Table 4 Summary of patients with postoperative infections
| Â | P1 | P2 | P3 | P7 |
|---|---|---|---|---|
Pre Op. treatment | 2016.08 Near total glossectomy, left MRND, left ALT flap reconstruction due to tongue cancer | 2019.05.23 Left maxilla sequestrectomy | 2019.08.21 Sequestrectomy and saucerization on #44–47 and extraction of #47 | 2018.06.19 Resection of left mandible retromolar area, both selective neck dissection due to SCC |
Op. date | 2019.04 | 2019.09 | 2019.12 | 2021.03 |
Onset | POD 6 | POD 14 | POD 10 | POD 8 |
I&D | O | X | O | O |
Culture | O | O | O | O |
Antibiotics | 2019.04.13–2019.04.24 Ceftriaxone sod 2 g IV | 2019.09.16–2019.10.01 Flomoxef 1000 mg bid IV | 2019.12.02–2019.12.12 Flomoxef 1000 mg bid IV | 2021.03.14–2021.03.26 Flomoxef 1000 mg bid IV |
2019.04.25 Tigecylibe 50 mg bid IV | 2019.10.02–2019. 10.14 Ampicillin & sulbactam 3 g qid IV | 2019.12.13–1019.12.15 Tazoferan 4.5 g tid INF Vancomycin 1 g bid IV | 2021.03.27–2021.04.02 Tazoferan 4.5 g qid INF | |
2019.04.26–2019. 04.29 Tazoferan 4.5 g tid INF | 2019.10.15–2019. 10. 22 Amoxicillin & clavulanic acid 375 mg tid | 2019.12.16–2019.12.30 Ampicillin & sulbactam 3 g qid IV |  | |
2019.04.30–2019.05.14 Ampicillin & sulbactam 3.0 g qid IV |  | 2019.12.31–2020.01.09 Cefixime 200 mg bid |  |